Cream4349

XERS Sept 10th PDUFA potential run up.

Pembelian
NASDAQ:XERS   Xeris Biopharma Holdings, Inc.
I bought XERS initially at 9.23 and have since then swung it from 11.50 to 12.50+ area. I believe it is heading into a short term bear trend which will precipitate a run up to the FDA PDUFA approval of it's diabetic non inject able. Short ratio is up as well.

I marked the resistance and support points that I think are major. There are no triangles to work off of only resistance and support points as well as moving averages. I will look to re-buy when i see a strong reversal from either the 9.30 or 10.50 areas. GLTA!

Hope you enjoy!

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.